Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote & News

Company Profile

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 9600

Fax: 858 794 9605

Website: www.calidibio.com

Address:

4475 Executive Drive, Suite 200, San Diego, United States

ka1954 Sep. 18 at 9:24 PM

$CLDI bro, in last few months, 100s of stocks have gone up 200%+. look at RETO it went from .35 to $20 and back to .20 cents now. nobody cares if a company/stock is a scam as long as some traders buy it and pop it big time. only question is if/when it will be this stock's turn ? it may not happen at all

0 · Reply

race2zero Sep. 18 at 7:33 PM

$CLDI what’s hard to understand? The company is run by scam artists, they are nowhere near a successful product, they only exist to pay themselves off of reverse splits and dilution. They had to move because they can’t afford their office anymore, they used to have a fake building as their headquarters on their website until they got called out on it and took it down.

0 · Reply

ka1954 Sep. 18 at 5:21 PM

$CLDI i am fucking seeing stocks go up 50%, 100%, 200% left and right, but this fucker is dead for so long. just dont understand

0 · Reply

tommy_john Sep. 17 at 10:25 PM

$CLDI had a small order waiting. Here we go

0 · Reply

race2zero Sep. 17 at 1:51 PM

$CLDI do not buy this POS, the only play here is to short it massively @CalidiOfficial

2 · Reply

race2zero Sep. 17 at 1:40 PM

$CLDI because they are absolute morons and scam artists @CalidiOfficial

0 · Reply

race2zero Sep. 17 at 1:32 PM

$CLDI under $1 any second now and they haven’t even started the dilution

0 · Reply

ka1954 Sep. 17 at 1:21 PM

$CLDI piece of shit company and stock. why these fuckers could announce dilution when this was at much higher rate? why announce at all time lows. fuckers !!!

0 · Reply

martyn78 Sep. 17 at 7:44 AM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $ALLR & $CLDI good status

0 · Reply

NetworkNewsWire Sep. 16 at 7:55 PM

Pancreatic Cancer Exploits Wound-Healing Mechanism to Evade Immune System $CLDI https://ibn.fm/w8cBi #techmedia #stocks

0 · Reply

Calidi prices 1.025M shares at $1.17 in registered direct offering

Sep 17, 2026, 9:10 AM EDT - 3 days ago

Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering

Sep 8, 2026, 8:00 AM EDT - 12 days ago

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Aug 13, 2026, 4:30 PM EDT - 5 weeks ago

Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Jul 27, 2026, 8:00 AM EDT - 7 weeks ago

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference

Jul 21, 2026, 8:00 AM EDT - 2 months ago

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers

Jul 20, 2026, 4:30 PM EDT - 2 months ago

Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026

Jul 8, 2026, 4:05 PM EDT - 2 months ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Jun 24, 2026, 8:00 AM EDT - 2 months ago

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit

Jun 23, 2026, 8:00 AM EDT - 2 months ago

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

2026-06-16T12:39:20.000Z - 3 months ago

Calidi receives pre-IND regulatory feedback from FDA for CLD-401

Jun 16, 2026, 8:00 AM EDT - 3 months ago

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026

2026-05-26T15:37:20.000Z - 3 months ago

Calidi announces online abstract acceptances at 2026 ASCO Meeting

May 26, 2026, 8:00 AM EDT - 3 months ago

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting

2026-05-22T22:05:57.000Z - 4 months ago

Calidi provides required NYSE American disclosure

May 22, 2026, 6:00 PM EDT - 4 months ago

Calidi Biotherapeutics Provides Required NYSE American Disclosure

May 14, 2026, 4:10 PM EDT - 4 months ago

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

May 13, 2026, 8:00 AM EDT - 4 months ago

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI

2026-04-21T13:29:48.000Z - 5 months ago

Calidi presents new data on CLD-401 at AACR

2026-04-20T12:54:38.000Z - 5 months ago

Calidi presents new data on in situ t-cell engagers at AACR

Apr 20, 2026, 8:00 AM EDT - 5 months ago

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Mar 27, 2026, 4:25 PM EDT - 5 months ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights

2026-03-12T12:17:48.000Z - 6 months ago

Calidi presents manufacturing process for CDI-401 at BioProcessing Summit

Mar 12, 2026, 8:00 AM EDT - 6 months ago

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing

Mar 9, 2026, 8:50 PM EDT - 6 months ago

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

2026-03-06T13:35:48.000Z - 6 months ago

Calidi prices 10.5M units at 50c in underwritten public offering

Mar 6, 2026, 8:30 AM EST - 6 months ago

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

2026-03-05T23:00:46.000Z - 6 months ago

Calidi announces offering of units, no amount given

Mar 5, 2026, 5:57 PM EST - 6 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

2026-02-20T13:11:19.000Z - 7 months ago

Calidi presents data on novel approach to use of BiTEs

Feb 20, 2026, 8:00 AM EST - 7 months ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

2026-02-12T13:10:13.000Z - 7 months ago

Calidi to present on approach to bispecific T-cell engagers using RedTail

Feb 12, 2026, 8:00 AM EST - 7 months ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

2026-01-28T13:13:01.000Z - 7 months ago

Calidi announces 2026 milestones

Nov 17, 2025, 8:00 AM EST - 10 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 13, 2025, 4:15 PM EST - 10 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

2025-11-10T13:20:35.000Z - 10 months ago

Calidi presents new data on CLD-401 at 2025 SITC annual meeting

2025-10-30T12:15:32.000Z - 10 months ago

Calidi announces new data to be presented on CLD-401 at 2025 SITC meeting

2025-10-22T12:11:42.000Z - 11 months ago

Calidi announces formation of its Scientific Advisory Board

Aug 21, 2025, 6:33 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

2025-08-20T13:20:27.000Z - 1 year ago

Calidi prices 1.47M units at $2.00 in underwritten public offering

Aug 20, 2025, 9:15 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 8, 2025, 4:15 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

2025-08-05T13:46:30.000Z - 1 year ago

Calidi Biotherapeutics Inc trading resumes

2025-08-05T13:43:07.000Z - 1 year ago

Calidi Biotherapeutics Inc trading halted, volatility trading pause

Jul 25, 2025, 4:45 PM EDT - 1 year ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 10, 2025, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 9, 2025, 2:01 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Apr 16, 2025, 9:30 AM EDT - 1 year ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE FLAG

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

ka1954 Sep. 18 at 9:24 PM

0 · Reply

race2zero Sep. 18 at 7:33 PM

0 · Reply

ka1954 Sep. 18 at 5:21 PM

$CLDI i am fucking seeing stocks go up 50%, 100%, 200% left and right, but this fucker is dead for so long. just dont understand

0 · Reply

tommy_john Sep. 17 at 10:25 PM

$CLDI had a small order waiting. Here we go

0 · Reply

race2zero Sep. 17 at 1:51 PM

$CLDI do not buy this POS, the only play here is to short it massively @CalidiOfficial

2 · Reply

race2zero Sep. 17 at 1:40 PM

$CLDI because they are absolute morons and scam artists @CalidiOfficial

0 · Reply

race2zero Sep. 17 at 1:32 PM

$CLDI under $1 any second now and they haven’t even started the dilution

0 · Reply

ka1954 Sep. 17 at 1:21 PM

$CLDI piece of shit company and stock. why these fuckers could announce dilution when this was at much higher rate? why announce at all time lows. fuckers !!!

0 · Reply

martyn78 Sep. 17 at 7:44 AM

0 · Reply

NetworkNewsWire Sep. 16 at 7:55 PM

Pancreatic Cancer Exploits Wound-Healing Mechanism to Evade Immune System $CLDI https://ibn.fm/w8cBi #techmedia #stocks

0 · Reply

NetworkNewsWire Sep. 15 at 7:35 PM

Systemic Challenges in US Health Care Push Cancer Patients to Fly to China $CLDI #BioMed #Cancer https://ibn.fm/0YWEE

0 · Reply

race2zero Sep. 14 at 1:32 PM

$CLDI dilution this week? Come on Eric Poma and Andrew Jackson, you guys are the laughing stock of the bio world, just end it already @CalidiOfficial

0 · Reply

race2zero Sep. 11 at 4:20 PM

$CLDI still here with a massive position just waiting for the dilution to start and this to nose dive

0 · Reply

race2zero Sep. 10 at 1:26 PM

$CLDI low borrow rate, shares available, dilution happening any day now…this is a shorts dream stock. No potential catalysts and run by complete morons…

0 · Reply

race2zero Sep. 10 at 1:24 PM

$CLDI LMAO

0 · Reply

Donald_J_Dumps Sep. 10 at 12:29 AM

$CLDI no more reverse splits incoming delisting.

0 · Reply

race2zero Sep. 4 at 2:55 PM

$RKTO I wish I could parlay shorts on here a two teamer with this and $CLDI would be amazing 😂😂😂

2 · Reply

race2zero Sep. 4 at 1:20 PM

$CLDI 600 volume😂😂😂😂 imagine the free fall when they start dilution! It’s going to be amazing, grab all the short shares you can, it will be life changing money

0 · Reply

NetworkNewsWire Sep. 3 at 7:19 PM

Administering Immunotherapy Prior to Surgery Improves Brain Cancer Treatment Outcomes $CLDI https://ibn.fm/AeG1P #biomedstocks #Cancer BMW 10am CLDI

0 · Reply

NetworkNewsWire Sep. 2 at 2:32 PM

Boosting Thymus Health Could Improve Treatment Outcomes in Lung Cancer $CLDI https://ibn.fm/0cwZi #tinygems #stocks

0 · Reply

race2zero Sep. 1 at 11:35 AM

$CLDI they are about to add over 9 million shares to the float 🤣🤣😂😂

1 · Reply

Market Cap	2.84M
Revenue (ttm)	0.00
Net Income (ttm)	-19.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.19

Volume	32,600
Avg Vol	246,937
Day's Range	N/A - N/A
Shares Out	2.58M
Stochastic %K	14%
Beta	1.32
Analysts	Strong Buy
Price Target	$10.00